Home
News
Your Voice
Links
Jobs
Sitemap
Contact
YOU ARE HERE: >
Kernow Clinical Commissioning Group
>
Formulary Information
>
Information Page
Home
Drugs
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Chapters
KCC Referral
Management System
Shared Care
Guidelines
Care Home
Resources
Local Resource
Packs
Chronic Pain
in Cornwall
Diabetes Resources
Respiratory Resources
Flu Resource Pack
Patient Group Direction (PGD)
Palliative Care Resources
Search
Search Drugs
Search BNF Categories
Notes
Click to View ALL BNF
Ch1 Gastro
Ch2 Cardio
Ch3 Respiratory
Ch4 CNS
Ch5 Infections
Ch6 Endocrine
Ch7 Obs & Gynae
Ch8 Malignant Disease
Ch9 Nutrition & Blood
Ch10 Muscuskeletal
Ch11 Eye
Ch12 Ear, Nose, Oropharynx
Ch13 Skin
Ch14 Immunological
Ch15 Anaesthesia
Ch19 Other Dugs
ch20 Dressings
ch21 Appliances
ch22 Incontinence appliances
ch23 Stoma appliances
>>
1. Drugs Used In Diabetes
2. Thyroid And Antithyroid Drugs
3. Corticosteroids (Endocrine)
4. Sex Hormones
5. Hypothalamic&Pituitary Hormones&Antioest
6. Drugs Affecting Bone Metabolism
7. Other Endocrine Drugs
>>
1. Short-Acting Insulins
2. Intermediate And Long-Acting Insulins
3. Hypodermic equipment
1. Sulfonylureas
2. Biguanides
3. Other Antidiabetics
0. Treatment Of Hypoglycaemia
0. Treatment of diabetic nephropathy and neuropathy
0. Screening and Monitoring Agents
(Click to View Drug List)
Cost
Cost
Packs
Packs
Items
Items
Loading…
Summary:
Formulary Notes (BNF Chapter)
Formulary Notes (BNF Chapter)
NICE Guidance (14)
NICE Guidance (14)
Other Links (6)
Other Links (6)
Important Local Documents (6)
Important Local Documents (6)
Notes for: Endocrine system
Last edited [17/05/2024 08:42:39]
NICE NG28 Type 2 diabetes in adults: management
NICE NG17 Type 1 diabetes in adults: diagnosis and management
NG18 Diabetes (type 1 and type 2) in children and young people
: diagnosis and management
Semaglutide
(
Ozempic)
setting
pre
-
set
quantities in
GP
pr
actice systems to prevent overprescribing
Guidelines for Blood Glucose Monitoring in Adults 2024
NICE Guidance (BNF Section Level) for - Drugs Used In Diabetes
15/07/2020
All NICE products (guidance etc.) on diabetes.
15/07/2020
PCOS metformin in women not planning pregnancy
12/05/2021
TA679 Dapagliflozin for treating chronic heart failure with reduced ejection fraction
13/05/2021
TA664 Liraglutide for managing overweight and obesity
20/09/2021
NG18 Diabetes (type 1 and type 2) in children and young people: diagnosis and management
20/09/2021
NG28 Type 2 diabetes in adults: management
20/09/2021
NG17 Type 1 diabetes in adults: diagnosis and management
15/03/2022
TA775 Dapagliflozin for treating chronic kidney disease
13/05/2022
TA773 Empagliflozin for treating chronic heart failure with reduced ejection fraction
28/06/2023
TA902 Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
09/11/2023
TA929 Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
29/01/2024
Tirzepatide for treating type 2 diabetes NICE TA924
19/06/2024
TA942 Empagliflozin for treating chronic kidney disease
NICE Guidance (BNF Chapter Level) for - Endocrine system
16/08/2023
Semaglutide for managing overweight and obesity NICE TA875
Other links (BNF Section Level) for - Drugs Used In Diabetes
15/07/2020
SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis
15/07/2020
Canagliflozin (Invokana, Vokanamet): signal of increased risk of lower extremity amputations observed in trial in high cardiovascular risk patients
15/07/2020
SGLT2 inhibitors: reports of Fournier’s gangrene (necrotising fasciitis of the genitalia or perineum)
15/07/2020
SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness
30/09/2020
DSU Sept 2020 Insulins (all types): Risk of cutaneous amyloidosis at injection site
Other Links (BNF Chapter Level) for - Endocrine system
19/06/2024
TA863 Somatrogon for treating growth disturbance in children and young people aged 3 years and over
Important Local Documents (BNF Chapter Level) for - Endocrine system
23/10/2020
NHS Kernow lancets factsheet September 2020
19/11/2021
NHS Kernow home blood glucose testing leaflet October 2021
27/05/2022
NHS Kernow updated guidance for prescribing of SGLT2 inhibitors May 2022
31/10/2022
Glucagon-like peptide-1 (GLP-1) analogue factsheet 2022
10/03/2023
Insulin needle factsheet Cornwall ICB
10/08/2020
NHS Kernow diabetes and frailty guidance June 2020
Loading…
Cornwall Joint Formulary Recommended Choices
(...Top)
Displaying 7 Drugs
Key:
First Line Drugs
Second Line Drugs
Specialist advised
Specialist Initiated Drugs
Hospital Only Drugs
Discouraged
No comment available
Name
Tariff
BNF Sub Paragraph
Metformin
500 mg tab Pack of 28
£0.84
Biguanides
Metformin
850 mg tab Pack of 56
£1.04
Biguanides
Metformin MR (Glucorex)
500 mg SR tablets Pack of 28
£0.95
Biguanides
Metformin SR
500 mg SR Tab Pack of 56
£1.97
Biguanides
Metformin (Sukkarto)
750 mg tablets SR Pack of 56
£2.87
Biguanides
Metformin SR
1000 mg SR tab Pack of 56
£2.95
Biguanides
Metformin
1 g tab Pack of 28
£40.29
Biguanides
© Kernow Clinical Commissioning Group 2024 - All Rights Reserved
The Sedgemoor Centre, Priory Road, St Austell, Cornwall, PL25 5AS